BioCentury
ARTICLE | Clinical News

Lidakol 10 percent n-docosanol cream: Began a Phase III trial in up to 320 patients, focusing on the early stage of cold sore eruption, to see if the agent can

April 24, 1995 7:00 AM UTC

Lidak Pharmaceuticals (LDAKA), La Jolla, Calif. Product: Lidakol 10 percent n-docosanol cream Indication: Herpes labialis Status: Began a Phase III trial in up to 320 patients, focusing on the early s...